Go Ad Free

Health Canada's steadfast assurances of rigorous oversight for COVID-19 mRNA vaccines are once again under fire, thanks to a groundbreaking Canadian study exposing DNA contamination levels that shatter regulatory limits.

As post-vaccination health worries persist, this peer-reviewed revelation demands urgent scrutiny – and answers from a government that's short on transparency.

The controversy can be confirmed through official government correspondence, where Conservative MP Dean Allison grilled officials on the safety of lipid nanoparticles (LNPs) in Pfizer-BioNTech's Comirnaty, Moderna's Spikevax, and boosters, plus the lipid drug Onpattro.

Allison's pointed questions zeroed in on mutagenic risks from vial impurities like residual solvents, metals, and elements, alongside LNP components such as polyethylene glycol (PEG) and the specter of complement activation-related pseudoallergy (CARPA).

CARPA is a sneaky immune reaction – not a classic allergy, but a first-exposure hypersensitivity that can trigger rashes, flushing, breathlessness, or even an anaphylaxis-like response. It's a wildcard in nanomedicine, yet Health Canada's guidance on risks fails to mention it entirely, eroding the foundation of informed consent.

Parliamentary Secretary Maggie Chi, speaking for the Minister of Health, brushed off concerns with confidence, citing "stringent regulatory oversight" per International Council for Harmonisation (ICH) guidelines.

The claim is that impurities fall below established daily exposure limits, and they’ve been deemed non-mutagenic.

LNPs have been fully characterized via non-clinical tests, with PEG cleared as safe, according to the government.

Yet they admit that no CARPA testing was required, since no standard exists for PEG hypersensitivity. Onpattro got the same clean bill.

Just days before this exchange, a peer-reviewed bombshell in Autoimmunity journal dismantled the rigorous regulatory oversight repeatedly espoused by Health Canada.

Led by Canadian molecular virologist Dr. David Speicher, with genomics expert Kevin McKernan and immunologist Dr. Jessica Rose, the scientists analyzed the contents of Ontario-sourced vaccine vials.

Using fluorometry and qPCR, the team uncovered DNA in significant excess of FDA and WHO “safe” limits of 10 nanograms (ng) per dose: Pfizer vials hit 36–153 times over, Moderna a staggering 112–627 times.

Worse, the study finally formally published findings that in addition to the massive DNA contaminants, Pfizer samples also harboured SV40 promoter-enhancer sequences – viral DNA fragments tied to genomic integration risks – at 0.25 to 23.72 ng per dose.

Moderna’s vials don’t contain the SV-40 sequence, likely due to manufacturing variances, but the overarching issue remains: DNA tucked inside LNPs evades breakdown, boosting transfection and potential harms like insertional mutagenesis or oncogene activation, as flagged in Moderna's own patents.

"Moderna’s patent states that a genetically engineered DNA... packaged in a lipid nanoparticle (LNP) is directly injected into a living host and could cause insertional mutagenesis and activation of oncogenes or the inhibition of tumor suppressor genes," the authors wrote. 

The study also dug into the US based Vaccine Adverse Events Reporting System (VAERS) and linked tainted lot numbers to severe adverse events, with some Pfizer batches logging up to 941 reports.

The authors warn that exposure to encapsulated DNA, especially repeatedly with cumulative booster doses, could fuel cancer or clotting.

This isn't mere oversight; it's a regulatory blind spot exposing Canadians to unknowns in nanotech's wild west.